Notice2023-07700
Interagency Coordinating Committee on the Validation of Alternative Methods; Notice of Public Meeting; Request for Public Input
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
April 12, 2023
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Abstract
The Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) will hold a public forum to share information and facilitate direct communication of ideas and suggestions from stakeholders. Interested persons may attend in person or view the meeting remotely by webcast. Time will be set aside for questions and public statements on the topics discussed. Registration is requested for attending in person and required for viewing the webcast and presenting oral statements. Information about the meeting and registration are available at https://ntp.niehs.nih.gov/go/ iccvamforum-2023.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 70 (Wednesday, April 12, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 70 (Wednesday, April 12, 2023)]
[Notices]
[Pages 22050-22051]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-07700]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Interagency Coordinating Committee on the Validation of
Alternative Methods; Notice of Public Meeting; Request for Public Input
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Interagency Coordinating Committee on the Validation of
Alternative Methods (ICCVAM) will hold a public forum to share
information and facilitate direct communication of ideas and
suggestions from stakeholders. Interested persons may attend in person
or view the meeting remotely by webcast. Time will be set aside for
questions and public statements on the topics discussed. Registration
is requested for attending in person and required for viewing the
webcast and presenting oral statements. Information about the meeting
and registration are available at <a href="https://ntp.niehs.nih.gov/go/iccvamforum-2023">https://ntp.niehs.nih.gov/go/iccvamforum-2023</a>.
DATES: Meeting: May 18 and 19, 2023, 9 a.m. to approximately 3 p.m. EDT
both days.
Registration for Onsite Meeting: Deadline is May 17, 2023.
Registration for Webcast: Deadline is May 19, 2023. Registration for
Oral Statements: Deadline is May 9, 2023.
Registration to attend in person is requested; registration to view
the webcast and present oral public statements is required.
ADDRESSES: Meeting Location: William H. Natcher Conference Center,
National Institutes of Health (NIH), Bethesda, MD 20892. Meeting web
page: Registration and other meeting materials are at <a href="https://ntp.niehs.nih.gov/go/iccvamforum-2023">https://ntp.niehs.nih.gov/go/iccvamforum-2023</a>. A preliminary agenda will be
posted on this page by May 2, 2023.
FOR FURTHER INFORMATION CONTACT: Dr. Nicole Kleinstreuer, Director,
National Toxicology Program Interagency Center for the Evaluation of
Alternative Toxicological Methods (NICEATM), email:
<a href="/cdn-cgi/l/email-protection#4c22252f2320296227202925223f383e2939293e0c222524622b233a"><span class="__cf_email__" data-cfemail="fc92959f939099d297909995928f888e9989998ebc929594d29b938a">[email protected]</span></a>, telephone: 984-287-3150.
SUPPLEMENTARY INFORMATION:
Background: ICCVAM, a congressionally mandated committee,
coordinates the development and validation of alternative testing
strategies that protect human health and the environment while
replacing, reducing, or refining animal use.
ICCVAM's goals include promotion of national and international
partnerships between governmental and nongovernmental groups, including
academia, industry, advocacy groups, and other key stakeholders. To
foster these partnerships ICCVAM initiated annual public forums in 2014
to share information and facilitate direct communication of ideas and
suggestions from stakeholders (79 FR 25136).
This year's meeting will be held on May 18 and 19, 2023. NICEATM
and ICCVAM members will give presentations on current activities
related to the development and validation of alternative test methods
and approaches.
There will be opportunities for participants to ask clarifying or
follow-up questions of the ICCVAM members about their presentations.
Instructions for submitting these questions will be provided to webcast
viewers prior to the event. The agenda will also include time for
public oral statements relevant to the ICCVAM mission and current
activities from participants who have registered to do so in advance.
Preliminary Agenda and Other Meeting Information: A preliminary
agenda will be posted by May 2 at <a href="https://ntp.niehs.nih.gov/go/iccvamforum-2023">https://ntp.niehs.nih.gov/go/iccvamforum-2023</a>. Interested individuals are encouraged to visit this
web page to stay abreast of the most current meeting information.
Meeting and Registration: This meeting is open to the public. The
public may attend the meeting at NIH, where attendance is limited only
by the space available, or view remotely by webcast. Those planning to
attend the meeting in person are encouraged to register at <a href="https://ntp.niehs.nih.gov/go/iccvamforum-2023">https://ntp.niehs.nih.gov/go/iccvamforum-2023</a> by May 17, 2023, to facilitate
planning for appropriate meeting space. Registration for the webcast is
required and is open through 3 p.m. EDT on May 19, 2023, at <a href="https://ntp.niehs.nih.gov/go/iccvamforum-2023">https://ntp.niehs.nih.gov/go/iccvamforum-2023</a>. Registrants will receive
instructions on how to access and participate in the webcast in the
email confirming their registration.
NIH visitor and security information is available at <a href="http://www.nih.gov/about/visitor/index.htm">http://www.nih.gov/about/visitor/index.htm</a>. Individuals with disabilities who
need accommodation to participate in this event should contact Milene
Brownlow at phone: 984-287-3364 or email:
[[Page 22051]]
<a href="/cdn-cgi/l/email-protection#0f6266636a616a216d7d6078616360784f61666721686079"><span class="__cf_email__" data-cfemail="533e3a3f363d367d31213c243d3f3c24133d3a3b7d343c25">[email protected]</span></a>. TTY users should contact the Federal TTY Relay
Service at 800-877-8339. Requests should be made at least five business
days in advance of the event.
Additional Health and Safety Guidance: Before attending a meeting
at an NIH facility, it is important that visitors review the NIH COVID-
19 Safety Plan at <a href="https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/Pages/default.aspx">https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/Pages/default.aspx</a> for information about requirements and
procedures for entering NIH facilities, especially when the COVID-19
community level is medium. If the COVID-19 level is high, the meeting
will be held virtually.
In addition, the Safer Federal Workforce website has FAQs for
visitors at <a href="https://www.saferfederalworkforce.gov/faq/visitors/">https://www.saferfederalworkforce.gov/faq/visitors/</a>. Please
note that if an individual has a COVID-19 diagnosis within 10 days of
the meeting, that person must attend virtually. (For more information
please read NIH's Requirements for Persons after Exposure at <a href="https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/persons-after-exposure.aspx">https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/persons-after-exposure.aspx</a> and What Happens
When Someone Tests Positive at <a href="https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/test-positive.aspx">https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/test-positive.aspx</a>.) Registration to attend the meeting virtually will be
available through the end of the meeting at <a href="https://ntp.niehs.nih.gov/go/iccvamforum-2023">https://ntp.niehs.nih.gov/go/iccvamforum-2023</a>. Please continue checking these websites for the
most up-to-date guidance as the meeting date approaches.
Request for Oral Public Statements: In addition to time for
clarifying or follow-up questions following scheduled presentations,
time will be allotted during the meeting for oral public statements
with associated slides on topics relevant to ICCVAM's mission. Separate
registration for those wishing to provide public statements is required
and is open through May 9, 2023, at <a href="https://ntp.niehs.nih.gov/go/iccvamforum-2023">https://ntp.niehs.nih.gov/go/iccvamforum-2023</a>. Any meeting attendee or webcast viewer may ask
clarifying questions during the appropriate times in the agenda. The
additional registration is only required for those who wish to give
separate public statements. The number and length of presentations may
be limited based on available time. Submitters will be identified by
their name and affiliation and/or sponsoring organization, if
applicable. Participants registered to present oral public statements
must email their statement to <a href="/cdn-cgi/l/email-protection#773e343421363a06021204031e18190437191e121f0459191e1f59101801"><span class="__cf_email__" data-cfemail="266f656570676b57534355524f49485566484f434e5508484f4e08414950">[email protected]</span></a> by May 12,
2023, to allow time for review by NICEATM and ICCVAM and posting to the
meeting page prior to the forum. Persons submitting public statements
and/or associated slides should include their name, affiliation (if
any), mailing address, telephone, email, and sponsoring organization
(if any) with the document. Guidelines for public statements are at
<a href="http://ntp.niehs.nih.gov/ntp/about_ntp/guidelines_public_comments_508.pdf">http://ntp.niehs.nih.gov/ntp/about_ntp/guidelines_public_comments_508.pdf</a>. Persons presenting oral public
statements will be contacted to arrange the logistics of their
presentations.
Written statements on topics relevant to ICCVAM's mission may be
submitted to support an oral public statement or as standalone
documents. These should be emailed to <a href="/cdn-cgi/l/email-protection#337a707065727e42465640475a5c5d40735d5a565b401d5d5a5b1d545c45"><span class="__cf_email__" data-cfemail="ace5efeffaede1ddd9c9dfd8c5c3c2dfecc2c5c9c4df82c2c5c482cbc3da">[email protected]</span></a> by
May 12, 2023. Public statements received prior to the May 12 deadline
will be distributed to NICEATM and ICCVAM members before the meeting.
Written public statements received after the deadline may be reviewed
by NICEATM and ICCVAM at a future date. Materials submitted to
accompany oral public statements or standalone written statements
should include the submitters name, affiliation (if any), mailing
address, telephone, email, and sponsoring organization (if any) with
the document. Guidelines for public statements are at <a href="http://ntp.niehs.nih.gov/ntp/about_ntp/guidelines_public_comments_508.pdf">http://ntp.niehs.nih.gov/ntp/about_ntp/guidelines_public_comments_508.pdf</a>.
Responses to this notice are voluntary. No proprietary, classified,
confidential, or sensitive information should be included in statements
submitted in response to this notice or presented during the meeting.
This request for input is for planning purposes only and is not a
solicitation for applications or an obligation on the part of the U.S.
Government to provide support for any ideas identified in response to
the request. Please note that the U.S. Government will not pay for the
preparation of any information submitted or for its use of that
information.
Background Information on ICCVAM and NICEATM: ICCVAM is an
interagency committee composed of representatives from 17 federal
regulatory and research agencies that require, use, generate, or
disseminate toxicological and safety testing information. ICCVAM
conducts technical evaluations of new, revised, and alternative safety
testing methods and integrated testing strategies with regulatory
applicability. ICCVAM also promotes the scientific validation and
regulatory acceptance of testing methods that more accurately assess
the safety and hazards of chemicals and products and replace, reduce,
or refine animal use.
The ICCVAM Authorization Act of 2000 (42 U.S.C. 285l-3) establishes
ICCVAM as a permanent interagency committee of the National Institute
of Environmental Health Sciences and provides the authority for ICCVAM
involvement in activities relevant to the development of alternative
test methods. Additional information about ICCVAM can be found at
<a href="https://ntp.niehs.nih.gov/go/iccvam">https://ntp.niehs.nih.gov/go/iccvam</a>.
NICEATM administers ICCVAM, provides scientific and operational
support for ICCVAM-related activities, and conducts and publishes
analyses and evaluations of data from new, revised, and alternative
testing approaches. NICEATM and ICCVAM work collaboratively to evaluate
new and improved testing approaches applicable to the needs of U.S.
federal agencies. NICEATM and ICCVAM welcome the public nomination of
new, revised, and alternative test methods and strategies for
validation studies and technical evaluations. Additional information
about NICEATM can be found at <a href="https://ntp.niehs.nih.gov/go/niceatm">https://ntp.niehs.nih.gov/go/niceatm</a>.
Dated: April 6, 2023.
Richard P. Woychik,
Director, National Institute of Environmental Health Sciences and
National Toxicology Program, National Institutes of Health.
[FR Doc. 2023-07700 Filed 4-11-23; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on April 12, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.